Open AccessA Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
Author(s) -
Richard T Davey,
Lori Dodd,
Michael A Proschan,
James Neaton,
Jacquie Neuhaus Nordwall,
Joseph S Koopmeiners,
John Beigel,
John Tierney,
H Clifford Lane,
Anthony S Fauci,
Moses B F Massaquoi,
Foday Sahr,
Denis Malvy
Publication year - 2016
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1604330
Subject(s) - medicine , ebola virus , randomized controlled trial , virology , medline , virus , intensive care medicine , political science , law
Data from studies in nonhuman primates suggest that the triple monoclonal antibody cocktail ZMapp is a promising immune-based treatment for Ebola virus disease (EVD).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom